SCHEMBL940641

SCHEMBL940641

CC(=O)C([NH])=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5488 0.78
SCHEMBL10782869 0.74
Butanedione SCHEMBL3273053 0.74
Hydrochloric Acid SCHEMBL11591553 0.74
SCHEMBL35038 0.73
SCHEMBL689736 0.72
Butanedione SCHEMBL1867426 0.72 TSHR (1.00)
Butanedione SCHEMBL20472 0.72
SCHEMBL12553070 0.70
Butanedione SCHEMBL15352914 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 161 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080089993-A1 Determining patient hydration level, configuring a fluid based on nutritional, mineral or vitamin deficiencies in addition to delivering drugs for various conditions; container is configured to selectively combine premeasured levels of nutraceuticals REMOTE CLINICAL SOLUTIONS, INC. (US) 2008-04-17 US claimed
EP-1784162-A2 SYSTEM AND METHOD FOR MODIFYING A FLUID FOR ORAL ADMINISTRATION Remote Clinical Solutions, Inc. (US) 2007-05-16 EP claimed
WO-2006023985-A9 SYSTEM AND METHOD FOR MODIFYING A FLUID FOR ORAL ADMINISTRATION REMOTE CLINICAL SOLUTIONS INC (US) 2007-04-12 WO claimed
WO-2006023985-A2 SYSTEM AND METHOD FOR MODIFYING A FLUID FOR ORAL ADMINISTRATION REMOTE CLINICAL SOLUTIONS, INC. (US) 2006-03-02 WO claimed
EP-0802808-B1 APPARATUS FOR ALTERING COMPOSITION OF NUTRITIONAL PRODUCT ABBOTT LAB (US) 2003-09-10 EP claimed
US-5738651-A Apparatus for altering composition of nutritional product during enteral tube feeding ABBOTT LABORATORIES (US) 1998-04-14 US claimed
EP-0802808-A1 APPARATUS FOR ALTERING COMPOSITION OF NUTRITIONAL PRODUCT Abbott Laboratories (US) 1997-10-29 EP claimed
WO-1996021480-A1 APPARATUS FOR ALTERING COMPOSITION OF NUTRITIONAL PRODUCT ABBOTT LABORATORIES (US) 1996-07-18 WO claimed
US-5531681-A Apparatus for altering composition of nutritional product during enteral tube feeding ABBOTT LABORATORIES (US) 1996-07-02 US claimed
EP-0636117-A4 METHOD OF ADMINISTERING PYRUVATE AND METHODS OF SYNTHESIZING PYRUVATE PRECURSORS. ABBOTT LAB (US) 1995-07-26 EP claimed
EP-0636117-A1 USE OF PYRUVAMIDE AND SELECTED PYRUVYL-AMINO ACIDS ABBOTT LABORATORIES (US) 1995-02-01 EP claimed
WO-1993021147-A1 METHOD OF ADMINISTERING PYRUVATE AND METHODS OF SYNTHESIZING PYRUVATE PRECURSORS ABBOTT LABORATORIES (US) 1993-10-28 WO claimed
EP-0268989-B1 IMIDAZOPYRIDINE COMPOUNDS AND PROCESSES FOR PREPARATION THEREOF FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-07-08 EP claimed
US-4831041-A ANTIULCER AGENTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-05-16 US claimed
EP-0268989-A1 Imidazopyridine compounds and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-06-01 EP claimed
US-RE49686-E1 Nitrogen-containing heterocyclic compound and use of same TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2023-10-10 US disclosed
US-RE48334-E1 Nitrogen-containing heterocyclic compound and use of same TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2020-12-01 US disclosed
EP-0219923-A1 Antibiotic derivatives, their production and use Takeda Chemical Industries, Ltd. (JP) 1987-04-29 EP disclosed
EP-0191989-A1 Antibiotic isoxazole derivatives, their production and use Takeda Chemical Industries, Ltd. (JP) 1986-08-27 EP disclosed
US-4566901-A PLANT SAFENING AGENTS CIBA-GEIGY CORPORATION (US) 1986-01-28 US disclosed